| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.009 |